Navigation Links
Shareholders Challenge Danaher/Kerr to Phase Out Mercury Tooth Fillings
Date:5/4/2009

Dominican Sisters of Hope, Others Question the Continuing Use of Mercury

WASHINGTON, May 4 /PRNewswire-USNewswire/ -- The Dominican Sisters of Hope, supported by Consumers for Dental Choice and the Mercury Policy Project, will present a resolution calling on the Danaher (NYSE: DHR) corporation to transition out of manufacturing mercury fillings at the company's annual shareholder meeting at the Mayflower Hotel in Washington D.C. this Tuesday, May 5 at 3 p.m. Danaher owns Kerr, the largest manufacturer of mercury amalgam.

"Mercury is highly toxic, can cause permanent harm to a fetus, to a child's developing brain or an adult's kidneys," said Valerie Heinonen, o.s.u., a consultant in corporate responsibility who will be representing the Dominican Sisters of Hope, which owns a block of Danaher shares. "The underserved are at great risk because of the continued use of mercury amalgam. We think it is wrong to put them at such risk when there are suitable alternatives available."

Consumers for Dental Choice and Mercury Policy Project will be armed with proxies, allowing them to vote shares of stock. The groups do not expect to get a majority vote of shareholders in their favor at this meeting but are using this platform to put Danaher on notice that there is a growing tide to forever erase the use of amalgam.

"The World Health Organization says no safe level of mercury exists," commented Michael Bender of the Mercury Policy Project. "The good news is that there are mercury-free alternatives that Kerr sells and that dentists are already using. Several countries have already banned its use, so why doesn't Kerr take a leadership role and stop polluting the planet with mercury?"

Bender notes that mercury is both a local and a global pollutant and that then Senator Barack Obama sponsored the mercury export ban that President Bush signed into law last year. President Obama went on to support the development of a legally binding treaty on mercury in February.

"The dangers of mercury are well-documented, but there is still one industry in the United States that won't let go and that is American dentists who continue to use mercury amalgam fillings," said Charles G. Brown, National Counsel for Consumers for Dental Choice.

For more information:

Advocates point out that Kerr also makes all the other dental filling materials, it can sell more resin (now the most common filling material), a more profitable product. Indeed, an analyst's report by Bank of America Securities says dental products manufacturers would be more profitable if amalgam is banned. (www.toxicteeth.org/mercuryfillings_BOAreport.cfm).

According to the Environmental Protection Agency (EPA) dental offices are the third largest user of mercury.EPA (2006) - Roadmap for Mercury p. 36 (http://www.epa.gov/mercury/pdfs/FINAL-Mercury-Roadmap-6-29.pdf)

In 2007, Bender gave testimony before the U.S. House Subcommittee on Domestic Policy of the Committee on Oversight and Government Reform on the Environmental Risks of Mercury Dental Fillings: http://mpp.cclearn.org/wp-content/uploads/2008/08/benders-testimony.pdf.


'/>"/>
SOURCE Mercury Policy Project
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Amylin Sends Letter to Shareholders
2. Baxter International Shareholders Meeting
3. Tennenbaum Encourages Shareholders to Vote the Blue Proxy for Tennenbaum Director Nominees at Online Resources Annual Meeting as Recommended by Riskmetrics/ISS and Proxy Governance
4. 2009 Annual Meeting of Shareholders
5. Johnson & Johnson to Webcast Annual Meeting of Shareholders
6. Tianyin Pharmaceutical Co., Inc. Series A Preferred Shareholders Approved Cash Dividend to Common Stockholders
7. Energy Partners, LTD Shareholders At Risk
8. MDS Announces Renewal of Companys Shareholders Rights Plan
9. Herley Chairman Addresses Shareholders at Annual Meeting of Shareholders March 17, 2009
10. Tepnel Shareholders Approve Acquisition by Gen-Probe
11. Leading Proxy Advisory Firm RiskMetrics Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... August 23, 2017 , ... A new ... Orthopaedic Surgeons , points out that therapeutic modalities (physical therapy) is an important ... to the report, a wider scope of physical therapy options is showing promising ...
(Date:8/22/2017)... ... August 22, 2017 , ... The old adage ... as simple as eating healthy foods. But this well-known piece of nutrition advice ... or breaking apart carbohydrates—depends not only on properties of the food but also ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... solutions, announced recently the availability of a new professional fee E/M leveling calculator ... their service to the healthcare industry. E/M coding is complex which supports the ...
(Date:8/22/2017)... ... August 22, 2017 , ... “Wilderness Voices”: a collection ... travel. “Wilderness Voices” is the creation of published author, Martha McKown, an ordained ... was inspired as a very young child when her older sisters studied High School ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... the Founder and Managing Member for t4 Leadership Development & Consulting. He has ... his definition of “success”: physician leadership development, servant leadership, data driven process improvement, ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Mostyn Law and Gulf Coast Regional Blood Center to host ... Mostyn Law family has had 3 members that needed ... Mostyn Law is partnering with Gulf Coast Regional Blood Center ... Blood supplies are running low. Gulf Coast Regional Blood Center,s ... August. That is why the blood center reached out to ...
(Date:8/15/2017)... Calif. , Aug. 15, 2017  AOTI Inc. announced today ... Oxygen Therapy Inc., has recently opened a New York City Office ... ever-increasing usage of its unique Topical Wound Oxygen (TWO 2 ) ... by the Accreditation Commission for Health Care (ACHC) under the company,s ... ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
Breaking Medicine Technology: